Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Delattre, O."" wg kryterium: Autor


Tytuł :
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.
Autorzy :
Tanaka I; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Chakraborty A; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Saulnier O; Institut Curie Research Center, SIREDO Oncology Center, Paris-Sciences-Lettres Research University, INSERM U830, Laboratory of Biology and Genetics of Cancers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, France.
Benoit-Pilven C; CNRS UMR 5239, Ecole Normale Supérieure de Lyon, Lyon, France.
Vacher S; Unité de Pharmacogénomique, Service de génétique, Institut Curie, Paris, France; Université Paris Descartes, Paris, France.
Labiod D; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Institut Curie, PSL Research University, Translational Research Department, Experimental Radiotherapy Platform, Orsay, France.
Lam EWF; Imperial College London, London, UK.
Bièche I; Unité de Pharmacogénomique, Service de génétique, Institut Curie, Paris, France; Université Paris Descartes, Paris, France.
Delattre O; Institut Curie Research Center, SIREDO Oncology Center, Paris-Sciences-Lettres Research University, INSERM U830, Laboratory of Biology and Genetics of Cancers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, France.
Pouzoulet F; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Institut Curie, PSL Research University, Translational Research Department, Experimental Radiotherapy Platform, Orsay, France.
Auboeuf D; CNRS UMR 5239, Ecole Normale Supérieure de Lyon, Lyon, France.
Vagner S; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Dutertre M; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2020 Mar 18; Vol. 48 (5), pp. 2676-2693.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Alternative Splicing/*genetics
Breast Neoplasms/*drug therapy
Doxorubicin/*therapeutic use
Proto-Oncogene Proteins/*metabolism
RNA-Binding Proteins/*metabolism
Adult ; Aged ; Aged, 80 and over ; Alternative Splicing/drug effects ; Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Doxorubicin/pharmacology ; Epithelial-Mesenchymal Transition/drug effects ; Epithelial-Mesenchymal Transition/genetics ; Exons/genetics ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; MCF-7 Cells ; Mice, Nude ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Middle Aged ; Protein Isoforms/metabolism ; RNA Splice Sites/genetics ; S Phase/drug effects ; Spliceosomes/metabolism
Czasopismo naukowe
Tytuł :
Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
Autorzy :
Guerrini-Rousseau L; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Dufour C; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Varlet P; Service de neuropathologie, Hôpital Sainte-Anne, Université Paris Descartes, Paris, France.
Masliah-Planchon J; PSL Research University, INSERM U830 Génétique et Biologie des Cancers Institut Curie, Paris, France.; Unité de génétique somatique, SIREDO pediatric oncology center, Institut Curie, Paris, France.
Bourdeaut F; PSL Research University, INSERM U830 Génétique et Biologie des Cancers Institut Curie, Paris, France.; Département d'oncologie Pédiatrique adolescents Jeunes Adultes, Institut Curie, Paris, France, SIREDO pediatric oncology center, Institut Curie, Paris, France.; Institut Curie SIRIC - Laboratoire de Recherche Translationnelle en Oncologie Pédiatrique, Institut Curie, Paris, France.
Guillaud-Bataille M; Département de Biologie et Pathologie Médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Abbas R; INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Bertozzi AI; Unité d' Hémato-Immuno-Oncologie pédiatrique, CHU Toulouse, Toulouse, France.
Fouyssac F; Onco-hématologie pédiatrique, Hôpital d'Enfants, CHU Nancy, Nancy, France.
Huybrechts S; Hematology-Oncology Unit, Hôpital Universitaire des Enfants Reine Fabiola, ULB Université libre de Bruxelles, Brussels, Belgium.
Puget S; Service de neurochirurgie pédiatrique, Hôpital Necker-Enfants malades, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Bressac-De Paillerets B; Département de Biologie et Pathologie Médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Caron O; PSL Research University, INSERM U830 Génétique et Biologie des Cancers Institut Curie, Paris, France.; Unité de génétique somatique, SIREDO pediatric oncology center, Institut Curie, Paris, France.; Département de Médecine Oncologique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Sevenet N; Laboratoire de génétique moléculaire, Département de bio-pathologie, Institut Bergonié, Bordeaux, France.; INSERM U1218, Université de Bordeaux, Bordeaux, France.; UFR des Sciences Pharmaceutiques, Université de Bordeaux, Bordeaux, France.
Dimaria M; Département de Médecine Oncologique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Villebasse S; Département de Médecine Oncologique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Delattre O; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Valteau-Couanet D; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Grill J; Unité Mixte de Recherche 8203 du Centre National de la Recherche Scientifique, Université Paris-Saclay, Villejuif, France.
Brugières L; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2018 Jul 05; Vol. 20 (8), pp. 1122-1132.
Typ publikacji :
Journal Article
MeSH Terms :
Germ-Line Mutation*
Heterozygote*
Biomarkers, Tumor/*genetics
Cerebellar Neoplasms/*pathology
Medulloblastoma/*pathology
Neoplasm Recurrence, Local/*pathology
Repressor Proteins/*genetics
Adolescent ; Adult ; Cerebellar Neoplasms/genetics ; Cerebellar Neoplasms/therapy ; Child ; Child, Preschool ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Infant ; Infant, Newborn ; Male ; Medulloblastoma/genetics ; Medulloblastoma/therapy ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/therapy ; Prognosis ; Retrospective Studies ; Risk Factors ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction.
Autorzy :
Deveau P; Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, Paris 75005, France.; Département de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.; University of Paris-Sud, Orsay, France.
Colmet Daage L; Département de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Oldridge D; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Childhood Cancer Research Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Bernard V; Institut Curie, PSL Research University, NGS platform ICGex, Paris 75005, France.
Bellini A; Département de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Chicard M; Département de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Clement N; Département de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.
Lapouble E; Unité de Génétique Somatique, Institut Curie, PSL Research University, Paris 75005, France.
Combaret V; Centre Léon-Bérard Laboratoire de Recherche Translationnelle, Lyon, France.
Boland A; Centre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie François Jacob, CEA, Evry 91057, France.
Meyer V; Centre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie François Jacob, CEA, Evry 91057, France.
Deleuze JF; Centre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie François Jacob, CEA, Evry 91057, France.
Janoueix-Lerosey I; Institut Curie, PSL Research University, INSERM U830, SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Equipe labellisée Ligue Nationale contre le cancer, Paris 75005, France.
Barillot E; Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, Paris 75005, France.
Delattre O; Institut Curie, PSL Research University, INSERM U830, SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Equipe labellisée Ligue Nationale contre le cancer, Paris 75005, France.
Maris JM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Childhood Cancer Research Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Schleiermacher G; Département de Recherche Translationnelle, Institut Curie, PSL Research University, INSERM U830, Laboratoire RTOP (Recherche Translationelle en Oncologie Pédiatrique), SIREDO Oncology Center (Care, Innovation and research for children and AYA with cancer), Paris 75005, France.; Département de Pédiatrie, Institut Curie, PSL Research University, Paris 75005, France.
Boeva V; Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, Paris 75005, France.; Institut Cochin, INSERM U1016, CNRS UMR 8104, Université Paris Descartes UMR-S1016, Paris 75014, France.
Pokaż więcej
Źródło :
Bioinformatics (Oxford, England) [Bioinformatics] 2018 Jun 01; Vol. 34 (11), pp. 1808-1816.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Clonal Evolution*
DNA Copy Number Variations*
Software*
Molecular Typing/*methods
Neoplasms/*genetics
Whole Genome Sequencing/*methods
Cluster Analysis ; DNA Mutational Analysis/methods ; Gene Frequency ; High-Throughput Nucleotide Sequencing/methods ; Humans ; Mutation ; Neoplasms/diagnosis
Czasopismo naukowe
Tytuł :
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
Autorzy :
Ferrucci V; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.; CEINGE Biotecnologie Avanzate, Naples, Italy.; European School of Molecular Medicine (SEMM), Milan, Italy.
de Antonellis P; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.; CEINGE Biotecnologie Avanzate, Naples, Italy.; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Ontario, Canada.
Pennino FP; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.; CEINGE Biotecnologie Avanzate, Naples, Italy.
Asadzadeh F; CEINGE Biotecnologie Avanzate, Naples, Italy.
Virgilio A; Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, Naples, Italy.
Montanaro D; CEINGE Biotecnologie Avanzate, Naples, Italy.
Galeone A; Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, Naples, Italy.
Boffa I; CEINGE Biotecnologie Avanzate, Naples, Italy.
Pisano I; CEINGE Biotecnologie Avanzate, Naples, Italy.
Scognamiglio I; CEINGE Biotecnologie Avanzate, Naples, Italy.
Navas L; Department of Veterinary Medicine and Animal Productions, Università degli Studi di Napoli Federico II, Naples, Italy.
Diana D; Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale della Ricerca, Naples, Italy.
Pedone E; Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale della Ricerca, Naples, Italy.
Gargiulo S; Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale della Ricerca, Naples, Italy.
Gramanzini M; Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale della Ricerca, Naples, Italy.
Brunetti A; CEINGE Biotecnologie Avanzate, Naples, Italy.; Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II, Naples, Italy.
Danielson L; Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK.
Carotenuto M; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.; CEINGE Biotecnologie Avanzate, Naples, Italy.
Liguori L; CEINGE Biotecnologie Avanzate, Naples, Italy.
Verrico A; Paediatric Neurosurgery, Ospedale Santobono-Pausilipon, Naples, Italy.
Quaglietta L; Paediatric Neurosurgery, Ospedale Santobono-Pausilipon, Naples, Italy.
Errico ME; Pathology Unit, Ospedale Santobono-Pausilipon, Naples, Italy.
Del Monaco V; CEINGE Biotecnologie Avanzate, Naples, Italy.
D'Argenio V; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.; CEINGE Biotecnologie Avanzate, Naples, Italy.
Tirone F; Genetic Control of Development-URT, Institute of Cell Biology and Neurobiology, National Research Council, Fondazione Santa Lucia, Rome, Italy.
Mastronuzzi A; Dipartimento di Onco-Ematologia, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Donofrio V; Pathology Unit, Ospedale Santobono-Pausilipon, Naples, Italy.
Giangaspero F; Dipartimento di Scienze Radiologiche, Oncologiche e Anatomo Patologiche, Università La Sapienza, Rome, Italy.; IRCCS Neuromed, Pozzilli, Italy.
Picard D; German Cancer Consortium (DKTK), Department of Paediatric Oncology, Haematology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
Remke M; German Cancer Consortium (DKTK), Department of Paediatric Oncology, Haematology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
Garzia L; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto ON, Canada.
Daniels C; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Ontario, Canada.
Delattre O; PSL Research University, Inserm U830, Equipe Labellisée Ligue contre le Cancer, Institut Curie, Paris, France.
Swartling FJ; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Weiss WA; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Salvatore F; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.; CEINGE Biotecnologie Avanzate, Naples, Italy.
Fattorusso R; Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Caserta, Italy.
Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK.
Taylor MD; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto ON, Canada.
Cinalli G; Paediatric Neurosurgery, Ospedale Santobono-Pausilipon, Naples, Italy.
Zollo M; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.; CEINGE Biotecnologie Avanzate, Naples, Italy.; European School of Molecular Medicine (SEMM), Milan, Italy.; DAI-Medicina Trasfusionale-Azienda Ospedaliera Universitaria Federico II, Naples, Italy.
Pokaż więcej
Źródło :
Brain : a journal of neurology [Brain] 2018 May 01; Vol. 141 (5), pp. 1300-1319.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media
MeSH Terms :
Carrier Proteins/*metabolism
Cerebellar Neoplasms/*metabolism
Gene Expression Regulation, Neoplastic/*physiology
Medulloblastoma/*metabolism
Neoplasm Metastasis/*physiopathology
PTEN Phosphohydrolase/*metabolism
Adolescent ; Animals ; Carrier Proteins/genetics ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cerebellar Neoplasms/pathology ; Child ; Child, Preschool ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Regulatory Networks ; Humans ; Infant ; Male ; Medulloblastoma/pathology ; Mice ; Mice, Inbred BALB C ; Models, Molecular ; Neoplasm Metastasis/genetics ; PTEN Phosphohydrolase/genetics ; Phosphoric Monoester Hydrolases ; Pyrimidinones/chemistry ; Pyrimidinones/pharmacology ; Signal Transduction/drug effects ; Signal Transduction/genetics ; Snail Family Transcription Factors/metabolism ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Tytuł :
Kids Enter the MATCH.
Autorzy :
Schleiermacher G; Affiliations of authors: Institut Curie, PSL Research University, France (GS, OD); Translational Research Department, SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Research Center, Institut Curie, Paris Sciences et Lettres Research University, Paris, France (GS); Department of Pediatric Oncology, Hospital Group, Institut Curie, Paris, France (GS); INSERM U830, Genetic and Biology of Pediatric Tumors Group, Institut Curie Research Center, Paris, France (OD).
Delattre O; Affiliations of authors: Institut Curie, PSL Research University, France (GS, OD); Translational Research Department, SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Research Center, Institut Curie, Paris Sciences et Lettres Research University, Paris, France (GS); Department of Pediatric Oncology, Hospital Group, Institut Curie, Paris, France (GS); INSERM U830, Genetic and Biology of Pediatric Tumors Group, Institut Curie Research Center, Paris, France (OD).
Pokaż więcej
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2016 Dec 31; Vol. 109 (5). Date of Electronic Publication: 2016 Dec 31 (Print Publication: 2017).
Typ publikacji :
Editorial; Comment
Opinia redakcyjna
Tytuł :
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
Autorzy :
Le Tourneau C; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Kamal M; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Tsimberidou AM; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Bedard P; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Pierron G; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Callens C; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Rouleau E; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Vincent-Salomon A; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Servant N; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Alt M; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Rouzier R; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Paoletti X; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Delattre O; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Bièche I; Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).
Pokaż więcej
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Nov 23; Vol. 108 (4). Date of Electronic Publication: 2015 Nov 23 (Print Publication: 2016).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Gene Expression Profiling*
Molecular Targeted Therapy/*trends
Neoplasms/*genetics
Neoplasms/*therapy
Precision Medicine/*methods
Signal Transduction/*drug effects
Algorithms ; Biomarkers, Tumor/genetics ; Clinical Trials as Topic ; DNA Copy Number Variations ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; Gene Dosage ; Gene Expression Regulation, Neoplastic ; Gene Silencing/drug effects ; Genes, Tumor Suppressor/drug effects ; High-Throughput Nucleotide Sequencing ; High-Throughput Screening Assays ; Humans ; Molecular Targeted Therapy/methods ; Precision Medicine/trends
Czasopismo naukowe
Tytuł :
Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma.
Autorzy :
Gibert B; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Delloye-Bourgeois C; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Gattolliat CH; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Meurette O; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Le Guernevel S; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Fombonne J; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Ducarouge B; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Lavial F; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Bouhallier F; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Creveaux M; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Negulescu AM; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Bénard J; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Janoueix-Lerosey I; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Harel-Bellan A; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Delattre O; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG).
Mehlen P; Apoptosis, Cancer and Development Laboratory-Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France (BG, CDB, OM, SLG, JF, BD, FL, MC, AMN, PM); CNRS UMR 8126, University Paris-Sud 11, Institut Gustave Roussy, Villejuif, France (C-HG, JB); Stem Cell and Brain Research Institute, INSERM U846, Bron, France (FB); INSERM, U830, Génétique et Biologie des Cancers, Institut Curie, Paris, France (IJL, OD); Department Epigenetics and Cancer FRE 3377, Centre National de la Recherche Scientifique, Commissariat à l'Energie Atomique Saclay, Gif-sur-Yvette, France (AHB); Université Paris-Sud, Gif-sur-Yvette, France (AH-B); Present address: INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, Brest, France (C-HG). .
Pokaż więcej
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2014 Oct 13; Vol. 106 (11). Date of Electronic Publication: 2014 Oct 13 (Print Publication: 2014).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Apoptosis*
Signal Transduction*
Cell Adhesion Molecules/*metabolism
MicroRNAs/*metabolism
Neuroblastoma/*metabolism
Tumor Suppressor Proteins/*metabolism
Hedgehog Proteins/metabolism ; Humans ; Kaplan-Meier Estimate ; Neuroblastoma/genetics ; Neuroblastoma/pathology ; Retrospective Studies ; Reverse Transcriptase Polymerase Chain Reaction ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
SegAnnDB: interactive Web-based genomic segmentation.
Autorzy :
Hocking TD; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Boeva V; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, FranceDepartment of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, FranceDepartment of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Rigaill G; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Schleiermacher G; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, FranceDepartment of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Janoueix-Lerosey I; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, FranceDepartment of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Delattre O; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, FranceDepartment of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Richer W; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Bourdeaut F; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Suguro M; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Seto M; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Bach F; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Vert JP; Department of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, FranceDepartment of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, FranceDepartment of Computer Science, Tokyo Institute of Technology, Tokyo 152-8552, Japan, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex 05, INSERM U900, Paris F-75248, France, Mines ParisTech, Centre for Computational Biology, 77300 Fontainebleau, Unité de Recherche en Génomique Végétale INRA-CNRS-Université d'Evry Val d'Essonne, Évry 91057, France, INSERM U830, Paris F-75248, France, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya-city 464-8681, Japan and INRIA-Sierra Project-Team, Département d'Informatique de l'École Normale Supérieure, Paris F-75013, France.
Pokaż więcej
Źródło :
Bioinformatics (Oxford, England) [Bioinformatics] 2014 Jun 01; Vol. 30 (11), pp. 1539-46. Date of Electronic Publication: 2014 Feb 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA Copy Number Variations*
Software*
Algorithms ; Chromosome Breakpoints ; Genomics/methods ; Internet
Czasopismo naukowe
Tytuł :
Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis.
Autorzy :
Stoll G; Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France, INSERM U900, Bioinformatique, biostatistique et épidémiologie d'un système complexe, Paris, France, Mines ParisTech, Fontainebleau, France, INSERM U830, Unité de Génétique et Biologie des Cancers, Paris, France and Institut Curie, Unité de génétique somatique, Paris, France.
Surdez D
Tirode F
Laud K
Barillot E
Zinovyev A
Delattre O
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2013 Oct; Vol. 41 (19), pp. 8853-71. Date of Electronic Publication: 2013 Aug 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Proliferation*
Gene Regulatory Networks*
Apoptosis/*genetics
Bone Neoplasms/*genetics
Oncogene Proteins, Fusion/*metabolism
Proto-Oncogene Protein c-fli-1/*metabolism
RNA-Binding Protein EWS/*metabolism
Sarcoma, Ewing/*genetics
Bone Neoplasms/metabolism ; Cell Line, Tumor ; Data Mining ; Gene Expression Regulation, Neoplastic ; Humans ; Models, Genetic ; Oncogene Proteins, Fusion/antagonists & inhibitors ; Oncogene Proteins, Fusion/genetics ; Proto-Oncogene Protein c-fli-1/antagonists & inhibitors ; Proto-Oncogene Protein c-fli-1/genetics ; RNA, Small Interfering/metabolism ; RNA-Binding Protein EWS/antagonists & inhibitors ; RNA-Binding Protein EWS/genetics ; Sarcoma, Ewing/metabolism ; Signal Transduction ; Systems Biology ; Transcriptome
Czasopismo naukowe
Tytuł :
Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.
Autorzy :
Park AK; College of Pharmacy, Sunchon National University, Korea.
Lee SJ
Phi JH
Wang KC
Kim DG
Cho BK
Haberler C
Fattet S
Dufour C
Puget S
Sainte-Rose C
Bourdeaut F
Grill J
Delattre O
Kim SK
Park WY
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2012 Feb; Vol. 14 (2), pp. 203-14. Date of Electronic Publication: 2011 Nov 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cerebellar Neoplasms/*mortality
Medulloblastoma/*mortality
Nuclear Proteins/*metabolism
Oncogene Proteins/*metabolism
Proto-Oncogene Proteins c-myc/*metabolism
Wnt Signaling Pathway/*physiology
Biomarkers, Tumor ; Cerebellar Neoplasms/classification ; Cerebellar Neoplasms/genetics ; Child ; Child, Preschool ; Chromosome Deletion ; Chromosomes, Human, Pair 17/genetics ; Chromosomes, Human, Pair 17/metabolism ; Female ; Gene Expression Profiling ; Genes, myc ; Humans ; Infant ; Male ; Medulloblastoma/classification ; Medulloblastoma/genetics ; N-Myc Proto-Oncogene Protein ; Nuclear Proteins/genetics ; Oncogene Proteins/genetics ; Prognosis ; Proto-Oncogene Proteins c-myc/genetics ; Signal Transduction/physiology ; Smith-Magenis Syndrome ; Survival Analysis
SCR Disease Name :
Chromosome 17 deletion
Czasopismo naukowe
Tytuł :
Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data.
Autorzy :
Boeva V; Institut Curie, Paris 75248, France. />Popova T
Bleakley K
Chiche P
Cappo J
Schleiermacher G
Janoueix-Lerosey I
Delattre O
Barillot E
Pokaż więcej
Źródło :
Bioinformatics (Oxford, England) [Bioinformatics] 2012 Feb 01; Vol. 28 (3), pp. 423-5. Date of Electronic Publication: 2011 Dec 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA Copy Number Variations*
Software*
Alleles ; Humans ; Loss of Heterozygosity ; Neoplasms/genetics ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł :
Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization.
Autorzy :
Boeva V; Institut Curie, INSERM, U900, Paris, France. />Zinovyev A
Bleakley K
Vert JP
Janoueix-Lerosey I
Delattre O
Barillot E
Pokaż więcej
Źródło :
Bioinformatics (Oxford, England) [Bioinformatics] 2011 Jan 15; Vol. 27 (2), pp. 268-9. Date of Electronic Publication: 2010 Nov 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA Copy Number Variations*
Software*
Genomics/*methods
Neoplasms/*genetics
Algorithms ; Base Composition ; Cell Line, Tumor ; Cytosine/analysis ; Guanine/analysis ; High-Throughput Nucleotide Sequencing ; Humans
Czasopismo naukowe
Tytuł :
SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data.
Autorzy :
Zeitouni B; INSERM U900, Institut Curie, Paris, France. />Boeva V
Janoueix-Lerosey I
Loeillet S
Legoix-né P
Nicolas A
Delattre O
Barillot E
Pokaż więcej
Źródło :
Bioinformatics (Oxford, England) [Bioinformatics] 2010 Aug 01; Vol. 26 (15), pp. 1895-6.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genomic Structural Variation*
Software*
Genome/*genetics
Genomics/*methods
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies